Skip to main content

Table 1 Patient clinical information

From: Simultaneous measurement of the size and methylation of chromosome 4qA-D4Z4 repeats in facioscapulohumeral muscular dystrophy by long-read sequencing

Sample ID

Patient ID

Genetic diagnosis

Age ranges at hospital inspection (years)

Sex

Age ranges at onset (years)

Asymmetric weakness

Facial weakness

Scapula weakness

Humeral weakness

Beevor’s sign

Other symptoms

Serum CK (IU/L)

1, 6

1

FSHD1

11–15

M

Birth

+

+

+

+

No data

Severe hearing loss

935

2

2

FSHD1

56–60

M

11–15

+

+

+

+

−

−

87

3

3

FSHD1

11–15

M

11–15

+

+

+

+

+

−

786

4

4

FSHD1

15–20

M

10–15

+

+

+

+

+

−

986

5

5

FSHD1

51–55

M

16–20

+

+

+

+

−

−

288

7

6

Suspected FSHD2

26–30

M

16–20

+

+

+

+

No data

−

1195

8

7

Suspected FSHD2

41–45

F

41–45

+

+

+

+

−

Mild hearing loss

380

9

8

Suspected FSHD1

16–20

M

11–15

+

+

+

+

−

−

887

10

9

Suspected FSHD1

61–65

F

41–45

+

+

+

+

+

−

259

11

10

Suspected FSHD1

71–75

F

46–50

+

+

+

+

−

Mild hearing loss

156

12

11

Suspected FSHD1

11–15

M

11–15

+

−

+

+

−

−

1262

13

12

Suspected FSHD1

21–25

F

Childhood

+

+

+

+

No data

−

241

14

13

Suspected FSHD1

16–20

F

Childhood

+

+

+

+

+

−

267

15

14

Suspected FSHD1

66–70

F

11–15

+

+

+

+

+

−

462

  1. Genetic diagnosis was based on the results of Southern blotting (Table 2). Beevor’s sign indicates lower abdominal muscles weakness
  2. CK creatine kinase